Keith Mikule
Impact in
- Cell Biology top 2%
- Microtubule and mitosis dynamics
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 19
- PARP inhibition in cancer therapy 13
-
- Ubiquitin and proteasome pathways 3
- Protein Kinase Regulation and GTPase Signaling 3
- Protein Tyrosine Phosphatases 3
- DNA Repair Mechanisms 2
- Co-authors
- Stephen Doxsey (3 shared papers)Wendy Zimmerman (1 shared paper)Wěi Li (2 shared papers)Youzhi Li (3 shared papers)Chiang J. Li (3 shared papers)Polla Hergert (1 shared paper)Bénédicte Delaval (1 shared paper)Philipp Kaldis (1 shared paper)
- Journals
- Cancer Research (4 papers)Molecular Cancer Therapeutics (4 papers)European Journal of Cancer (3 papers)Journal of Neuroscience (2 papers)Cell Cycle (2 papers)
- Partner nations
- United StatesSouth KoreaHungary
In The Last Decade
Keith Mikule
27 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 93
- Cell Biology 505
- Oncology 739
- Toxicology 63
- Molecular Biology 927
- Cancer Research 178
Countries citing papers authored by Keith Mikule
This map shows the geographic impact of Keith Mikule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Mikule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Mikule more than expected).
Fields of papers citing papers by Keith Mikule
This network shows the impact of papers produced by Keith Mikule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Mikule. The network helps show where Keith Mikule may publish in the future.
Co-authors
The 25 scholars most cited alongside Keith Mikule, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 385 | |
| 2 | 2005 | 260 | |
| 3 | 2006 | 243 | |
| 4 | 2019 | 184 | |
| 5 | 2018 | 117 | |
| 6 | 2017 | 105 | |
| 7 | 2013 | 87 | |
| 8 | 2002 | 57 | |
| 9 | 2014 | 37 | |
| 10 | 2003 | 28 | |
| 11 | 2006 | 27 | |
| 12 | 1998 | 24 | |
| 13 | 1999 | 24 | |
| 14 | 1996 | 23 | |
| 15 | 2018 | 22 | |
| 16 | 2015 | 13 | |
| 17 | 2019 | 12 | |
| 18 | 2007 | 9 | |
| 19 | 2016 | 9 | |
| 20 | Thrombin causes pseudopod detachment via a pathway involving cytosolic phospholipase A2 and 12/15-lipoxygenase products. | 2000 | 8 |
About Keith Mikule
Keith Mikule is a scholar working on Oncology, Molecular Biology, Cell Biology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 1.7k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (13 papers), Microtubule and mitosis dynamics (5 papers), Ubiquitin and proteasome pathways (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Protein Tyrosine Phosphatases (3 papers), DNA Repair Mechanisms (2 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Cell Biology (505 citations), Oncology (739 citations), Toxicology (63 citations), Molecular Biology (927 citations) and Cancer Research (178 citations). Keith Mikule has collaborated with scholars based in United States, South Korea and Hungary. Frequent co-authors include Stephen Doxsey, Wendy Zimmerman, Wěi Li, Youzhi Li, Chiang J. Li, Polla Hergert, Bénédicte Delaval, Philipp Kaldis, Harry A. Rogoff and Yuan Gao. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, European Journal of Cancer, Journal of Neuroscience and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.